These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16738535)

  • 21. Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning.
    Chen ZY; Wang L; Asavaritkrai P; Noguchi CT
    J Neurosci Res; 2010 Nov; 88(14):3180-8. PubMed ID: 20806411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study.
    Maggioni D; Nicolini G; Chiorazzi A; Meregalli C; Cavaletti G; Tredici G
    J Neurosci Res; 2010 Nov; 88(14):3171-9. PubMed ID: 20722073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging technologies in the delivery of erythropoietin for therapeutics.
    Murua A; Orive G; Hernández RM; Pedraz JL
    Med Res Rev; 2011 Mar; 31(2):284-309. PubMed ID: 19967731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The receptor that tames the innate immune response.
    Brines M; Cerami A
    Mol Med; 2012 May; 18(1):486-96. PubMed ID: 22183892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin: powerful protection of ischemic and post-ischemic brain.
    Nguyen AQ; Cherry BH; Scott GF; Ryou MG; Mallet RT
    Exp Biol Med (Maywood); 2014 Nov; 239(11):1461-75. PubMed ID: 24595981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts.
    Csete M; Rodriguez L; Wilcox M; Chadalavada S
    Neurosci Lett; 2004 Apr; 359(1-2):124-6. PubMed ID: 15050726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin: multiple physiological functions and regulation of biosynthesis.
    Sasaki R; Masuda S; Nagao M
    Biosci Biotechnol Biochem; 2000 Sep; 64(9):1775-93. PubMed ID: 11055378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of anemia and renal cytokine production on erythropoietin production during blood-stage malaria.
    Chang KH; Stevenson MM
    Kidney Int; 2004 May; 65(5):1640-6. PubMed ID: 15086902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin and the vascular wall: the controversy continues.
    Jelkmann W; Elliott S
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23 Suppl 1():S37-43. PubMed ID: 22682530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
    Liu R; Suzuki A; Guo Z; Mizuno Y; Urabe T
    J Neurochem; 2006 Feb; 96(4):1101-10. PubMed ID: 16417583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative Erythropoietin Receptors in the Nervous System.
    Ostrowski D; Heinrich R
    J Clin Med; 2018 Feb; 7(2):. PubMed ID: 29393890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
    Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH
    J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin and renoprotection.
    Bahlmann FH; Fliser D
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):15-20. PubMed ID: 19077684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?
    Grasso G; Sfacteria A; Cerami A; Brines M
    Neuroscientist; 2004 Apr; 10(2):93-8. PubMed ID: 15070483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.
    Sharples EJ; Patel N; Brown P; Stewart K; Mota-Philipe H; Sheaff M; Kieswich J; Allen D; Harwood S; Raftery M; Thiemermann C; Yaqoob MM
    J Am Soc Nephrol; 2004 Aug; 15(8):2115-24. PubMed ID: 15284297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury.
    Kato S; Aoyama M; Kakita H; Hida H; Kato I; Ito T; Goto T; Hussein MH; Sawamoto K; Togari H; Asai K
    J Neurosci Res; 2011 Oct; 89(10):1566-74. PubMed ID: 21833990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney.
    Gong H; Wang W; Kwon TH; Jonassen T; Li C; Ring T; FrøkiAEr J; Nielsen S
    Kidney Int; 2004 Aug; 66(2):683-95. PubMed ID: 15253723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure.
    Johnson DW; Pat B; Vesey DA; Guan Z; Endre Z; Gobe GC
    Kidney Int; 2006 May; 69(10):1806-13. PubMed ID: 16598197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.